Health officials are tracking a newly identified COVID-19 variant, dubbed “Cicada,” as it spreads across several U.S. States, including Ohio. The variant, a sublineage of Omicron, is currently under investigation to determine its potential impact on transmission, severity, and vaccine effectiveness.
The emergence of Cicada comes as public health agencies continue to monitor the evolving landscape of the virus. While currently not considered a dominant strain, its presence in multiple states warrants close observation. The Centers for Disease Control and Prevention (CDC) is actively monitoring the situation and providing updates as more data becomes available. Understanding the characteristics of new variants like Cicada is crucial for informing public health strategies and protecting communities.
According to reports, the “Cicada” variant, specifically the BA.2.86 lineage, has been detected in Ohio, Pennsylvania, Rhode Island, South Carolina, Texas, Utah, Vermont, Virginia, and Wyoming. A map detailing the variant’s spread is available from the U.S. Department of Health and Human Services here.
What is the Cicada COVID Variant?
The Cicada variant, scientifically known as BA.2.86, is a subvariant of Omicron. It has garnered attention due to a significant number of mutations compared to previous strains. These mutations have prompted scientists to investigate whether the variant could potentially evade existing immunity from prior infection or vaccination. The World Health Organization (WHO) has designated BA.2.86 as a “variant under monitoring” according to their website.
Early data suggests that the Cicada variant does not currently pose an immediate, severe threat. However, the high number of mutations necessitates ongoing surveillance to assess its behavior and potential impact. Researchers are working to determine whether the variant causes more severe illness, spreads more easily, or is less susceptible to current treatments and vaccines.
Current Spread and Detection in Ohio
As of today, the number of confirmed cases of the Cicada variant in Ohio remains relatively low. The Ohio Department of Health is actively conducting genomic sequencing to track the spread of the variant within the state. The Ohio Department of Health website provides the latest information on COVID-19 trends and variants in the state.
Health officials emphasize the importance of continued vigilance and adherence to recommended preventative measures. These include staying up-to-date on vaccinations, practicing good hygiene, and considering wearing a mask in crowded indoor settings. Testing remains a key component of tracking the virus and identifying new cases, including those caused by the Cicada variant.
Symptoms and Severity
Currently, there is no evidence to suggest that the Cicada variant causes different symptoms than other Omicron subvariants. Common symptoms of COVID-19, including those associated with BA.2.86, include fever, cough, sore throat, fatigue, muscle aches, and loss of taste or smell. Some individuals may as well experience gastrointestinal symptoms such as nausea, vomiting, or diarrhea.
The severity of illness appears to be similar to that of other circulating variants. However, individuals who are unvaccinated, elderly, or have underlying health conditions remain at higher risk of severe illness. It’s vital to consult a healthcare professional if you experience symptoms of COVID-19.
What to Expect Next
Public health officials will continue to closely monitor the spread of the Cicada variant and assess its potential impact. Genomic sequencing efforts will be crucial for tracking the variant’s evolution and identifying any changes in its characteristics. The CDC and WHO will provide updated guidance as more information becomes available. The ongoing surveillance and research efforts are essential for informing public health strategies and protecting communities from the evolving threat of COVID-19.
Stay informed about the latest developments regarding the Cicada variant and other COVID-19 updates. Share this information with your friends and family to help promote awareness and encourage preventative measures. Your comments and questions are welcome below.
Disclaimer: This information is for general knowledge and informational purposes only, and does not constitute medical advice. This proves essential to consult with a qualified healthcare professional for any health concerns or before making any decisions related to your health or treatment.
